The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
Supported by Plan International, the partnership will help treat over 1,000 children annually
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
The standout story remains Wegovy, particularly its new oral formulation
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma
Subscribe To Our Newsletter & Stay Updated
